Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Sports Med. 2010 Sep 20;39(1):164–172. doi: 10.1177/0363546510378088

Figure 2.

Figure 2

Images taken of the samples with the median OARSI score for each treatment group: A) PBS, B) HA, C) LUB, and D) LUB+HA. Note the loss of superficial zone cells (S), proteoglycan (P) and increased surface fibrillation (F) in the PBS- and HA-treated sections.